The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice

British Journal of Pharmacology
K J Rogers, J A Thornton

Abstract

1. The administration of either iproniazid or tranylcypromine to mice potentiates the acute toxicity of pethidine, morphine, pentazocine and phenazocine.2. Blood levels of pentazocine in mice pretreated with tranylcypromine do not differ from the levels in animals not receiving the monoamine oxidase (MAO) inhibitor.3. There is no correlation between changes in brain and liver MAO activity and the increased pethidine toxicity.4. A comparison is made between the change in pethidine toxicity and the changes in the concentration of cerebral noradrenaline, dopamine and 5-hydroxytryptamine following the injection of tranylcypromine.5. It is concluded that the increased toxicity of potent analgesics in combination with MAO inhibitors is not due to a decelerated metabolism of the analgesic drug, but is related to an increased concentration of cerebral 5-hydroxytryptamine. A critical level of this monoamine, in the brain, may be necessary before the drug interaction will take place.

References

Nov 1, 1965·Biochemical Pharmacology·M Krajl
Sep 27, 1952·British Medical Journal·J W DUNDEE, L F TINCKLER
Jun 1, 1956·British Journal of Pharmacology and Chemotherapy·B K BHATTACHARYA, G P LEWIS
Nov 1, 1958·British Medical Journal·C PAPP, S BENAIM
Sep 1, 1959·Annals of the New York Academy of Sciences·M CHESSINC C SCOTT
Jan 13, 1962·Annals of the New York Academy of Sciences·W H FUNDERBURKJ A SCHNEIDER
Jul 1, 1962·Biochemical Pharmacology·D M SERRONE, J M FUJIMOTO
Jan 1, 1964·Biochemical Pharmacology·R D MAGUSB E RIEDEL
Aug 13, 1960·British Medical Journal·J C SHEE
Aug 1, 1965·British Journal of Pharmacology and Chemotherapy·A H Loveless, D R Maxwell

Citations

Dec 1, 1992·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·W H Noble, A Baker
Jan 1, 1989·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·D G Wells, A R Bjorksten
Jul 1, 1971·Canadian Anaesthetists' Society Journal·M M Ghoneim
Jan 1, 1997·European Archives of Psychiatry and Clinical Neuroscience·S E HiltonH J Möller
Jan 1, 1970·European Journal of Pharmacology·R SamaninL Valzelli
Jan 1, 1971·European Journal of Pharmacology·K J Rogers
May 1, 1973·European Journal of Pharmacology·P K Gessner
Aug 1, 1976·European Journal of Pharmacology·E T IwamotoE L Way
Apr 29, 1986·European Journal of Pharmacology·A E TakemoriP S Portoghese
Feb 15, 1971·Life Sciences. Pt. 1: Physiology and Pharmacology·C C Hug, T Oka
Feb 1, 1973·Toxicology and Applied Pharmacology·M PfefferM Alteras
Jan 26, 1991·Lancet·G L ZornbergB M Cohen
Jan 10, 2002·American Journal of Therapeutics·Kenneth S LattaRobert L Barkin
Oct 30, 1998·Fundamental & Clinical Pharmacology·P K Gillman
May 4, 2007·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Si-Sheng HuangNan-Ying Chiu
Mar 1, 1973·Toxicology and Applied Pharmacology·S Y Yeh, C W Gorodetzky
Jan 1, 1980·British Journal of Clinical Pharmacology·S E SMITHP J Tyrer
Dec 1, 1984·Annals of Emergency Medicine·C H LindenC Strehlke
Jan 1, 1979·Journal of Neuroscience Research·A W Crossley, P Slater
Apr 30, 1999·Journal of Psychopharmacology·P K Gillman
Jan 8, 1971·Nature·M B Bowers, H D Kleber
Mar 3, 1999·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·A L Weiner
Aug 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·B Browne, S Linter
May 1, 1977·The Journal of Pharmacy and Pharmacology·C Blundell, P Slater
Feb 1, 1979·Anaesthesia and Intensive Care·T C Brown, N M Cass
Jan 1, 1981·The Journal of Pharmacy and Pharmacology·J W FindlayH J Leighton
Nov 1, 1971·The Journal of Pharmacy and Pharmacology·L Ahtee, L Saarnivaara
Oct 1, 1972·The Journal of Pharmacy and Pharmacology·P K Gessner, A G Soble

Related Concepts

Antinociceptive Agents
Metazoa
Drug Augmentation
Iproniazid
Meperidine Hydrochloride
Reversible Inhibitors of Monoamine Oxidase
Morphine Sulfate (2: 1), Pentahydrate
Talwin
Narphen
Jatrosom

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Systemic Juvenile Idiopathic Arthritis

Systemic juvenile idiopathic arthritis is a rare rheumatic disease that affects children. Symptoms include joint pain, but also fevers and skin rashes. Here is the latest on this disease.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Pontocerebellar Hypoplasia

Pontocerebellar hypoplasias are a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments. Here is the latest research on pontocerebellar hypoplasia.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.

Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.